Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

Swical-Energy Extra-Strength Liquid

Canada Type III Ongoing · initiated 2024-05-27

Labelling. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns…

Tisseel Kit

Canada Type II Ongoing · initiated 2024-05-23

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Sanis Health Duloxetine 60 mg Capsule

Canada Type I Ongoing · initiated 2024-05-16

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Sandoz Fesoterodine Fumarate 8 mg tablet

Canada Type II Ongoing · initiated 2024-05-16

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

REDDY-SAPROPTERIN 100mg powder for solution

Canada Type I Ongoing · initiated 2024-05-03

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Viatris Inc

US Class II Completed · initiated 2024-04-30

Failed Impurities/Degradation Specifications

Viatris Inc

US Class II Completed · initiated 2024-04-30

Failed Impurities/Degradation Specifications

Miracle Reds

Canada Unclassified Ongoing · initiated 2024-04-23

Product safety. Verify if your product is affected.Stop using this product if you have an immune-compromised condition, such as AIDS or lymphoma (cancer), or if…

PMS-Duloxetine 30 mg

Canada Type I Ongoing · initiated 2024-04-17

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

PMS-Duloxetine 60 mg

Canada Type I Ongoing · initiated 2024-04-17

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

I-131 Diagnostic Capsule

Canada Type III Ongoing · initiated 2024-04-17

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

JAMP-Guanfacine XR 4 mg

Canada Type II Ongoing · initiated 2024-04-10

Product quality - Product safety. Check your or your child's pill bottle to ensure that the green JAMP Guanfacine XR 4mg tablets do not have any brown or amber-…

Eyesaline Emergency Eyewash; Eyesaline Solution

Canada Type II Ongoing · initiated 2024-04-04

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

JAMP-Rabeprazole 20 mg

Canada Type II Ongoing · initiated 2024-04-02

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Viatrexx Ki-Diab

Canada Type II Ongoing · initiated 2024-03-25

Product quality. Verify if your product is affected.Contact the recalling firm if you have any questions about the recall.Report any health product related side…

JAMP Cephalexin Suspension; 125 mg/5 mL Cephalexin For Oral Suspension USP

Canada Type III Ongoing · initiated 2024-03-21

Product quality. Verify if your product is affected.Contact the recalling firm if you have any questions about the recall.Report any health product related side…

Equate Vitamin D Droplets Kids 400IU

Canada Type III Ongoing · initiated 2024-03-18

Packaging. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns…

FOLIC ACID 1MG

Canada Type II Ongoing · initiated 2024-03-12

Product quality. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Report any health product re…

Thyroid PX

Canada Unclassified Ongoing · initiated 2024-03-04

Product quality. Health care professionals:Consider the benefits and risks of prescribing or keeping patients on the affected health product(s).Follow the recom…

Nutracelle Nutramin Vitamin for Kids

Canada Type III Ongoing · initiated 2024-02-20

Dosage. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Co…

PDP-Desonide

Canada Type III Ongoing · initiated 2024-02-20

Packaging. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns…

APO-MOMETASONE

Canada Type II Ongoing · initiated 2024-02-19

Contamination. Do not use the affected product. Return it to your local pharmacy for proper disposal.Seek medical attention if you or your child have used this …

VitalBulk Niacin

Canada Type II Ongoing · initiated 2024-02-09

Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health con…

TEVA-DILTIAZEM XC

Canada Type II Ongoing · initiated 2024-02-07

Health products. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Klorane KeratinCaps

Canada Type III Ongoing · initiated 2024-02-01

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…